These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12957568)

  • 1. The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia.
    van der Hoorn MA; van Luxemburg-Heijs SA; van Bergen CA; Bongaerts R; Willemze R; Falkenburg JH
    Methods; 2003 Oct; 31(2):113-9. PubMed ID: 12957568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.
    Smit WM; Rijnbeek M; van Bergen CA; Fibbe WE; Willemze R; Falkenburg JH
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10152-7. PubMed ID: 9707616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes.
    Falkenburg JH; Wafelman AR; Joosten P; Smit WM; van Bergen CA; Bongaerts R; Lurvink E; van der Hoorn M; Kluck P; Landegent JE; Kluin-Nelemans HC; Fibbe WE; Willemze R
    Blood; 1999 Aug; 94(4):1201-8. PubMed ID: 10438707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity.
    Faber LM; van Luxemburg-Heijs SA; Veenhof WF; Willemze R; Falkenburg JH
    Blood; 1995 Oct; 86(7):2821-8. PubMed ID: 7670118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Falkenburg JH; Goselink HM; van der Harst D; van Luxemburg-Heijs SA; Kooy-Winkelaar YM; Faber LM; de Kroon J; Brand A; Fibbe WE; Willemze R
    J Exp Med; 1991 Jul; 174(1):27-33. PubMed ID: 2056279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.
    Choudhury A; Gajewski JL; Liang JC; Popat U; Claxton DF; Kliche KO; Andreeff M; Champlin RE
    Blood; 1997 Feb; 89(4):1133-42. PubMed ID: 9028934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
    Hoyle C; Bangs CD; Chang P; Kamel O; Mehta B; Negrin RS
    Blood; 1998 Nov; 92(9):3318-27. PubMed ID: 9787169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units.
    Molldrem JJ; Clave E; Jiang YZ; Mavroudis D; Raptis A; Hensel N; Agarwala V; Barrett AJ
    Blood; 1997 Oct; 90(7):2529-34. PubMed ID: 9326217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells.
    Norde WJ; Overes IM; Maas F; Fredrix H; Vos JC; Kester MG; van der Voort R; Jedema I; Falkenburg JH; Schattenberg AV; de Witte TM; Dolstra H
    Blood; 2009 Mar; 113(10):2312-23. PubMed ID: 19074734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia.
    Falkenburg JH; Smit WM; Willemze R
    Immunol Rev; 1997 Jun; 157():223-30. PubMed ID: 9255633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia.
    Zhong RK; Rassenti LZ; Kipps TJ; Chen J; Law P; Yu JF; Ball ED
    Biol Blood Marrow Transplant; 2002; 8(10):557-68. PubMed ID: 12434951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells.
    Mutis T; Schrama E; van Luxemburg-Heijs SA; Falkenburg JH; Melief CJ; Goulmy E
    Blood; 1997 Aug; 90(3):1083-90. PubMed ID: 9242539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
    Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
    J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of leukemia-reactive cytotoxic T lymphocytes from HLA-identical donors of patients with chronic myeloid leukemia using modifications of a limiting dilution assay.
    Smit WM; Rijnbeek M; van Bergen CA; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1998 Mar; 21(6):553-60. PubMed ID: 9543058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones.
    van der Harst D; Goulmy E; Falkenburg JH; Kooij-Winkelaar YM; van Luxemburg-Heijs SA; Goselink HM; Brand A
    Blood; 1994 Feb; 83(4):1060-6. PubMed ID: 8111046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells.
    von dem Borne PA; van Luxemburg-Heijs SA; Heemskerk MH; Jedema I; Mulder A; Willemze R; Falkenburg JH
    Leukemia; 2006 Jun; 20(6):1040-6. PubMed ID: 16525495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients.
    Fujii S; Fujimoto K; Shimizu K; Ezaki T; Kawano F; Takatsuki K; Kawakita M; Matsuno K
    Cancer Res; 1999 May; 59(9):2150-8. PubMed ID: 10232602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.